Search results
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 1 day agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 4 days agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
Ultragenyx executive sells over $440k in company stock By Investing.com
Investing.com· 3 days agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) has reported a significant stock transaction by one of...
Ultragenyx director Sanders Corazon sells $71,390 in company stock By Investing.com
Investing.com· 5 days agoThe shares were sold at a price of $41.10 each. Sanders Corazon, who serves as a director of...
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 4 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoIt's important to note that shares are not forming a chart pattern for investors to watch. On April...
What to know about neurocutaneous syndromes
Medical News Today· 2 days agoWhat are neurocutaneous syndromes? Read on to learn about this group of neurological conditions, including its different types and symptoms.
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) to Post Q2 2024 Earnings of ($0.37) Per Share, William Blair...
ETF DAILY NEWS· 3 days agoTenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) – Research analysts at William Blair issued their Q2 2024 EPS estimates for shares of Tenaya Therapeutics in a research note< ...
Amid big Bayer shakeup, drugmaker loses Berkeley-based biotech chief - San Francisco Business Times
The Business Journals· 5 days agoJens Vogel, who as global head of biotech led Bayer AG's push into cell therapy manufacturing from...
Study Elucidates Skin Signs of VEXAS Syndrome
Medscape· 2 days agoSkin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....